American Bio Medica Makes Key Additions to Sales Force; Four Drug Test Industry Sales Pros to Expand Direct Sales Efforts.Business Editors/Health/Medical Writers KINDERHOOK, N.Y.--(BUSINESS WIRE)--Feb. 17, 2004 American Bio Medica medica (māˑ·dē·k Corporation (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : ABMC ABMC American Battle Monuments Commission ABMC Alexian Brothers Medical Center (Illinois) ABMC Aviation Battle Management Concept ABMC Arrowbear Music Camp (California) ) today announced the addition of four experienced sales professionals to the company's sales group. Joining ABMC are: Lyn Cappel, Kathleen Deines, W.B. Buddy DuVall and Lauren Light, all of whom previously held sales roles within the drug test industry. According to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. Todd Bailey, ABMC Vice President of Sales and Marketing, "These four new sales professionals bring with them the insights and experiences specifically needed to help ABMC continue its successful targeting of strategic business opportunities in the developing point of collection drugs of abuse testing market. Bailey added, "The addition of these key people to ABMC further strengthens our commitment to become the number one point of collection drug screen company in the world. Bringing Lyn, Kathy, Buddy and Lauren to ABMC strengthens an already successful direct sales program that will further complement existing and new strategic alliances. The fact that these experienced professionals chose to join our team speaks volumes about our products and the culture at ABMC, and the fact that we brought them here should signal that we are poised to aggressively chase key accounts." Cappel has over 12 years experience in the corporate drug testing and clinical diagnostic markets with companies including Quest Diagnostics Quest Diagnostics Incorporated (NYSE: DGX) is a United States corporation which provides clinical laboratory services . The company also has a business presence in England and Mexico. Quest Diagnostics is a member of the Fortune 500 and the S&P 500. Incorporated and Novacare, Inc. She brings direct sales, sales management Sales Management Role and Goal Importance of sales management is critical for any commercial organization. Expanding business in not possible without increasing sales volumes, and effective sales management goal is to organize sales team work in such a manner that ensures a and marketing experience with her to ABMC. Deines brings over 15 years sales and management experience from substance abuse companies including Quest Diagnostics Incorporated and PharmChem Laboratories, Inc. She has served in sales training, sales management and key account executive positions. DuVall brings over 14 years of experience in the drug-testing field. Most recently he was Occupational Testing Services Manager at Laboratory Corporation of America and prior to that he was Sports Testing National Account Manager at Quest Diagnostics Incorporated. He also served as Program Coordinator for drug testing at the U.S. Olympic Committee from 1989 - 1992. Light brings over 12 years of proven sales experience with both Northwest Drug Testing and Laboratory Corporation of America. Her focus since 1991 has been on selling drug testing programs to Fortune 500 companies, physicians and hospital accounts. About American Bio Medica Corporation American Bio Medica Corporation is a biotechnology company that develops manufactures and markets accurate, cost-effective immunoassay Immunoassay An assay that quantifies antigen or antibody by immunochemical means. The antigen can be a relatively simple substance such as a drug, or a complex one such as a protein or a virus. diagnostic test kits, including some of the world's most effective point of collection tests for drugs of abuse. The Company and its worldwide distribution network target the workplace, government, corrections, clinical and educational markets. ABMC's Rapid Drug Screen(R), Rapid One(R), Rapid Tec(R) and Rapid Tec Cup(TM) products test for the presence or absence of drugs of abuse in urine urine, clear, amber-colored fluid formed by the kidneys that carries metabolic wastes out of the body (see urinary system). As the blood circulates it collects excretory products from the tissues and these substances are separated from the blood by the kidneys and , while OralStat(R) tests for the presence or absence of drugs of abuse in saliva saliva Thick, colourless fluid constantly present in the mouth, composed of water, mucus, proteins, mineral salts, and amylase, an enzyme that breaks down starches. One to two litres are produced daily by the salivary glands. . ABMC has been named among the 2002 Deloitte & Touche Technology Fast 500, a listing of the fastest-growing technology companies in North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. . This release may contain forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. . These forward-looking statements involve risks and uncertainties that could cause actual results to differ, and such differences could be material. Such risks and uncertainties include, but are not limited to, the following: continued acceptance of the Company's products, increased levels of competition in our industry, the acceptance of new products, inherent risks associated with product development and intellectual property rights, the Company's dependence on key personnel, third party sales and suppliers. There can be no assurance that the Company will be successful in addressing such risks and uncertainties and the Company assumes no duty to update any forward-looking statements based upon actual results. Investors are strongly encouraged to review the section entitled en·ti·tle tr.v. en·ti·tled, en·ti·tling, en·ti·tles 1. To give a name or title to. 2. To furnish with a right or claim to something: "Risk Factors" in the Company's annual report on Form 10-KSB for the fiscal year ended December 31, 2002, and quarterly reports on Form 10-QSB on file with the Securities and Exchange Commission for a discussion of risks and uncertainties that could affect operating results and the market price of the Company's common shares. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion